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Abstract 
Background: PCR can be positive weeks after effective malaria treatment, potentially leading to over diagnose of 
recrudescence and re-infections. The DNA detected by PCR post-treatment might stem from residuals of destroyed 
asexual parasites, or from live gametocytes. The objective of this clinical observational study was to describe the 
presence of positive PCR for Plasmodium falciparum and Plasmodium vivax in follow-up samples post-treatment from 
returned travellers, and the proportion of positive PCR due to gametocytes.
Methods: Whole blood was collected during hospitalization and outpatient routine follow-up from 13 patients 
with imported malaria. DNA was extracted applying QIAamp DNA Blood Mini Kit, while mRNA was collected and 
extracted applying PAXgene Blood RNA Tubes and Kit. All DNA samples (N = 25) were analysed with a genus-specific 
cytb real-time SYBR PCR, and P. falciparum DNA samples (N = 22) were also analysed with a falciparum-specific varATS 
real-time TaqMan PCR. All the mRNA samples (N = 18) were analysed with both a genus-specific 18S rRNA RT-PCR and 
a gametocyte-specific Pfs25 (P. falciparum)/Pvs25 (P. vivax) RT-PCR.
Results: Latest samples were collected at day 1 (n = 2) and from day 11–54 (n = 11) after treatment. Genus DNA cytb 
PCR was positive up to 49 days after effective treatment, and 18S rRNA transcripts from active P. falciparum parasites 
were detectable for at least 11 days. Gametocyte-specific mRNA was detected at latest only two days after treatment. 
Among six patients with late positive PCR for P. falciparum, four had high parasitaemia at admittance (6–30%), while 
two had parasitaemia < 2%. Late detection of P. vivax was not found by any of the PCR methods.
Conclusions: DNA-based PCR can be positive up to at least seven weeks after curative malaria treatment, potentially 
leading to over-diagnose of recrudescence and re-infections. Based on the observations in this study, it is unclear if 
the DNA origins from residuals of destroyed parasites or live gametocytes, warranting further investigations.
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Background
Polymerase chain reaction (PCR) detecting Plasmo-
dium DNA is the most sensitive method for diagnosing 
malaria, and used as reference method for routine diag-
nostics and in epidemiological surveys. However, PCR 
can be positive weeks after effective malaria treatment, 




1 Norwegian National Advisory Unit On Tropical Infectious Diseases, Unit 
for Infectious Diseases, Department of Medicine, Haukeland University 
Hospital, Bergen, Norway
Full list of author information is available at the end of the article
Page 2 of 6Haanshuus and Mørch  Malar J          (2020) 19:296 
re-infections [1]. Residuals of destroyed asexual parasites, 
and live or destroyed gametocytes, are possible sources 
of post-treatment Plasmodium DNA in patients cured of 
their malaria infection. Gametocytes are sexual forms of 
malaria parasites responsible for transmission between 
humans after completion of their cycle in mosquitoes. 
They cause no clinical symptoms in the human host. In 
Plasmodium falciparum, immature gametocytes seques-
ter in internal host organs, particularly in the bone mar-
row, and undergo five morphological development stages 
in the course of 7–12  days, hence only mature gameto-
cytes circulate in the blood until they die of age [2, 3]. It 
has been estimated from mathematical modelling that 
P. falciparum gametocyte carriage may persist for up to 
55 days after treatment [4]. Primaquine (PQ) is the only 
drug effective against mature gametocytes, and is added 
to artemisinins in routine treatment of P. falciparum in 
many malaria-endemic areas to prevent transmission [5, 
6]. Artemisinin also has some effect on gametocyte car-
riage duration, through the effect on immature game-
tocytes and rapid killing of asexual parasites [5]. Less is 
known about Plasmodium vivax gametocytes. It seems 
that immature P. vivax gametocytes sequester mainly in 
the bone marrow, similar to P. falciparum [7]. However 
they mature much faster than P. falciparum gametocytes, 
they are commonly present before symptoms and before 
parasite detection by microscopy, and live only for up to 
three days [2, 8].
Several malaria PCR methods have been introduced 
applying different amplification targets on the parasite 
genome. The real-time PCR targeting var gene acidic ter-
minal sequence (varATS) on the chromosomal genome, 
and cytochrome b (cytb) on the mitochondrial genome, 
are among the most sensitive ones [9]. The varATS gene 
exists in 59 copies for each parasite nucleus [10], while 
the number of copies of the cytb gene varies depending 
on parasite stage; ring-stage parasites have about 20 cop-
ies, and gametocytes about 160 copies [11, 12]. Game-
tocyte-specific mRNA transcripts can be detected by 
reverse transcript (RT)-PCR methods [13, 14].
The objective of this clinical observational study was to 
describe the presence of positive PCR for P. falciparum 
and P. vivax in follow-up samples post-treatment from 
returned travellers, and the proportion of positive PCR 
due to gametocytes, applying PCR methods detecting 
Plasmodium DNA and gametocyte-specific mRNA.
Methods
Patient material
Blood samples from adult patients, diagnosed with 
malaria by microscopy and/or rapid diagnostic test at 
Haukeland University Hospital, Bergen, were collected 
in the period 2013–2015. Blood samples were collected 
during hospitalization and at routine follow-up in the 
outpatient clinic at 11–54  days after treatment. Clinical 
information and results from routine microscopy was 
collected retrospectively from patient records.
PCR methods
DNA was extracted from EDTA whole blood applying 
QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Ger-
many), while mRNA was collected and extracted apply-
ing PAXgene Blood RNA Tubes and Kit (PreAnalytiX, 
Hombrechtikon, Switzerland), according to the manufac-
turer’s instructions.
All the DNA samples (N = 25) were analysed with a 
genus-specific cytb real-time SYBR PCR, and the P. fal-
ciparum DNA samples (N = 22) were also analysed with 
a falciparum-specific varATS real-time TaqMan PCR, 
following previously published methods [9, 10]. All 
the mRNA samples (N = 18) were analysed both with a 
genus-specific 18S rRNA RT-PCR (detecting mRNA 
transcripts produced by all parasite stages), and a game-
tocyte-specific Pfs25 (P. falciparum)/Pvs25 (P. vivax) 
RT-PCR detecting female gametocytes, following previ-
ously published methods [14]. In addition, quantitative 
analysis was performed for the cytb real-time PCR and 
Pfs25/Pvs25 RT-PCR runs by applying tenfold dilution 
series of customized plasmids designed with EcoRI lin-
earized q-PCR template and a pUCminusMCS vector 
backbone (OriGene Technologies, Rockville, MD, USA). 
All samples were run in triplicates, and a positive result 
was defined as at least two out of three detections.
Results
The PCR results applying DNA and mRNA template, 
including mean  Ct values as well as quantitative num-
bers, are presented in Table  1. Genus DNA cytb PCR 
was positive up to 49 days after effective treatment, and 
18S rRNA transcripts from active P. falciparum parasites 
were detectable for at least 11  days. Microscopy and/or 
PCR detected gametocytes in 67% (8/12) patients, but 
gametocyte-specific mRNA was detected at latest only 
two days after treatment. Late detection of P. vivax was 
not found by any of the PCR methods.
All patients were asymptomatic and had negative 
microscopy at outpatient follow-up visits. The association 
between positive PCR, microscopy findings and clinical 
characteristics is presented in Table 2. Six patients with P. 
falciparum were treated with artesunate intravenously, fol-
lowed by a full oral course of artemether-lumefantrine (AL) 
or atovaquone-proguanil (AP), while two received only AL 
and one only AP. All P. vivax patients, and no P. falciparum 
patients, received primaquine. Among the six patients with 
late P. falciparum positive PCR (day 11–49), four had high 
parasitaemia (6–30%) while two had parasitaemia < 2% at 
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admittance, and three had gametocytes detected. A clear 
association between low/high P. falciparum parasitaemia 
and duration of positive PCR detections was not found. 
One patient with late positive PCR was of Norwegian ori-
gin, while five were from sub-Saharan Africa and had lived 
from 10–46 years in Norway. Two of the patients with late 
positive PCR were immunodeficient with HIV or sickle cell 
disease.
Discussion
In this observational study, DNA-based PCR was posi-
tive up to seven weeks after effective malaria treatment. 
No patients had clinical signs of recrudescence, and there 
was no risk of re-infection. This is in line with a previous 
report that found positive malaria PCR after six weeks 
in a group of returned travellers in Sweden [1]. Positive 
PCR for weeks after effective treatment of infections is a 
Table 1 Plasmodium DNA and gametocyte-specific mRNA detections among malaria patients after treatment (N = 13)
rxn reaction
a Gametocytes seen by microscopy





Cytb PCR  (Ct)










No. 1 P.f + P.m 0 Pos (2) Pos (24) 1.1 × 103 Pos (26)
1 Pos (1) Pos (25) 4.3 × 102 Pos (28) Pos (17) Pos (29) 3.2 × 103
No. 2 P.f 0 Pos (4) Pos (18) 5.7 × 105 Pos (19)
1 Pos (4) Pos (21) 7.0 × 105 Pos (22) Pos (12) Pos (34) 95
No. 3 P.f 0 Pos (12)
1 Neg Pos (22) 3.7 × 104 Pos (26)
2 Neg Pos (23) 1.5 × 104 Pos (29)
11 Neg Pos (30) 200 Pos (35) Pos (25) Neg
No. 4 P.f 0 Pos (< 1)*
31 Neg Neg Neg Neg
No. 5 P.f 0 Pos (< 1)
32 Neg Pos (37) 2 Neg Neg
No. 6 P.f 0 Pos (2) Pos (19) 3.9 × 105 Pos (20)
1 Pos (< 0.5) Pos (24) 7.7 × 103 Pos (27) Pos (17) Pos (31) 420
37 Neg Pos (39) 1 Neg Neg
No. 7 P.f 0 Pos (10) Pos (15) 4.0 × 106 Pos (16)
4 Neg Pos (25) 6.3 × 103 Pos (29) Pos (23) Neg
11 Neg Pos (29) 400 Pos (35) Pos (24) Neg
39 Neg Neg Neg Neg Neg
No. 8 P.f 0 Pos (30) Pos (16) 1.8 × 106 Pos (18)
1 Pos (6) Pos (16) 3.0 × 106 Pos (17) Pos (7) Pos (29) 2.2 × 103
45 Neg Pos (34) 16 Neg Neg Neg
No. 9 P.f 0 Pos (6)*
49 Neg Pos (34) 11 Pos (36) Neg Neg
No.10 P.v 0 Pos (0.5)
2 Pos* Pos (7) Pos (17) 9.6 × 106
No. 11 P.v 0 Pos (0.5)a
6 Neg Pos (39) 1 Neg Neg
No. 12 P.v 0 Pos Pos (22) 4.8 × 104
23 Neg Neg Neg Neg
No. 13 P.v 0 Pos
54 Neg Neg Neg Neg Neg
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common phenomenon; a study investigating detectable 
DNA after treatment of Chlamydia trachomatis, Neis-
seria gonorrhoeae and Trichomonas vaginalis infections, 
reported that PCR could be positive up to three weeks 
post-treatment [15].
Molecular studies have shown that most individuals 
with asexual parasites also have sub-microscopic game-
tocyte carriage [16]. In general, the level of circulating 
gametocytes is low, about 5% compared to other para-
site-stages. Gametocytes were detected by microscopy 
and/or RT-PCR in 67% (8/12) of the patients in the pre-
sent study. However, gametocyte-specific mRNA was 
not detected in the late follow-up samples, similar to that 
reported by Vafa Homann et  al. in Sweden [1], which 
might indicate that the detection of Plasmodium DNA 
origin from residuals of destroyed parasites. The phago-
cytic system has the potential to remove up to 40–80% of 
malaria infected red blood cells (RBCs) in a few days, but 
due to sequestration of infected RBCs in organs, the time 
of complete clearance of parasite residuals is unknown 
Table 2 PCR results associated with microscopy findings and clinical characteristics
AL artemether-lumefantrine, A artesunate IV (intravenous), PA atovaquone-proguanil, Q quinine IV, C chloroquine, P primaquine, HIV human immunodeficiency virus, 
SSA sub-Saharan Africa, SEA Southeast Asia
a Gametocytes seen by microscopy
b Detection of 18S mRNA transcripts (Produced by all parasite stages)
c Detection of gametocyte-specific mRNA











No. 1 P.f + P.m 0 Pos (2) Pos 35 AL SSA/1 HIV
1 Pos (1) Posb,c
No. 2 P.f 0 Pos (4) Pos 2 A, AL SSA/8 HIV
1 Pos (4) Posb,c




No. 4 P.f 0 Pos (< 1)a 38 AP SSA/10
31 Neg Neg
No. 5 P.f 0 Pos (< 1) 7 AL SSA/46
32 Neg Pos
No. 6 P.f 0 Pos (2) Pos 9 Q, A, AL SSA/21
1 Pos (< 0.5) Posb,c
37 Neg Pos




No. 8 P.f 0 Pos (30) Pos 3 A, Norway
1 Pos (6) Posb,c Erythrocyte
45 Neg Pos apheresis, AL
No. 9 P.f 0 Pos (6)a 13 A, AP, AL SSA/17 Sickle cell disease
49 Neg Pos
No.10 P.v 0 Pos (0.5) 10 AP, P SEA/30
2 Posa Posb,c
No. 11 P.v 0 Pos (0.5)a Not known AP, P SSA
6 Neg Pos
No. 12 P.v 0 Pos Pos 2 A, AP, P Norway
23 Neg Neg
No. 13 P.v 0 Pos 6 C, P Norway
54 Neg Neg
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[17]. Drug treatment may also have contributed to clear 
gametocytes. All the P. falciparum patients were treated 
with artemisinin, which has some gametocidal effect, 
and all P. vivax patients were treated with PQ, which 
has a strong gametocidal effect. In a study from Kenya 
and Tanzania estimating gametocyte carriage following 
treatment with non-artemisinin drugs, artemisinin, and 
artemisinin in combination with PQ, duration of gameto-
cytaemia was 55, 13 and 6 days, respectively [4].
Collection, handling and analysis of mRNA is challeng-
ing [18, 19], and due to the instability of mRNA versus 
DNA, difference in sensitivity between the methods can 
be a factor that may underestimate late gametocytae-
mia in this study. A study investigating a similar game-
tocyte-specific Pfs25 RT-PCR, reported that in dilution 
series down to 0.05 and 0.01 gametocytes/µl, the lowest 
density samples were often negative [20]. In the present 
study, the quantitative values detected by cytb DNA PCR 
in samples > 30 days after treatment correspond to ≤ 0.05 
gametocytes/µl, so potentially these could have gameto-
cytaemia below detection level of mRNA RT-PCR.
In the study from Kenya and Tanzania investigating 
gametocytaemia, a nucleic acid sequence based ampli-
fication (NASBA) method detecting Pfs25 mRNA was 
applied, a method slightly more sensitive than Pfs25 RT-
PCR; gametocytes were found in 5–78% of the samples 
at day 14, and 12–48% at day 28 [4]. However, compared 
to returned travellers in the present study, patients in 
malaria-endemic areas may have a higher level of game-
tocyte carriage post-treatment due to reasons such as 
late admission and delayed treatment, use of less effec-
tive drugs, self-medication with sub-optimal regimes, 
re-infection, or gametocyte carriage that originate from 
previous undetected low-density infections.
Looking only at the two DNA-based PCR assays, the 
cytb PCR detected more late follow-up samples than 
varATS PCR. Hypothetically this could be explained by 
detection of gametocytes, since the cytb method detect 
mitochondrial DNA present in large amounts in gameto-
cytes. In regard to copy number, the cytb PCR is about 
2.5 times more sensitive in detecting gametocytes than 
varATS PCR, while the varATS PCR is about three times 
more sensitive than cytb PCR in detecting asexual para-
sites. In a study applying field samples from Tanzania, 
the sensitivity in detecting low level parasitaemia by dif-
ferent real-time malaria PCR methods where compared, 
and the varATS PCR was then found to be more sensitive 
than cytb PCR [9].
Two samples 11 days after treatment were positive by 
18S rRNA RT-PCR (mRNA), but not by the gameto-
cyte specific Pfs25 RT-PCR, indicating that possible live 
asexual parasites circulated in the bloodstream in low 
densities at this point. Although, negative gametocyte 
specific Pfs25 RT-PCR due to lower sensitivity could also 
be possible. The quantitative levels by the DNA PCR after 
11  days correspond to < 5 parasites/µl. Post-treatment 
asexual parasites that survive until they are cleared by the 
immune system continue to produce gametocytes, which 
also could support the reported phenomenon of gameto-
cyte carriage for several weeks after treatment [4].
For the P. vivax samples, a high level of mRNA from 
gametocytes was detected by the Pvs25 RT-PCR at day 2 
after treatment, but both mRNA assays were negative for 
the late follow-up samples. The cytb DNA PCR was posi-
tive at day 6, though with parasitaemia as low as 0.025 
parasites/µl. These results are consistent with the short 
duration of gametocytaemia in P. vivax [2]. The results 
for P. vivax also support that persistent positive P. falci-
parum PCR could be caused by gametocytes; if positive 
P. falciparum PCR was caused only by DNA residuals, 
it would be expected that also P. vivax was PCR positive 
days/weeks after treatment similar in P. falciparum infec-
tions. An association between high P. falciparum parasi-
taemia and persistent PCR would intuitively be expected. 
However, similar to that reported by Vafa Homann 
et  al. among Swedish travellers [1], no clear association 
between low/high level of parasitaemia and persistent 
positive PCR was identified in the present study.
Conclusions
DNA-based PCR can be positive up to at least seven 
weeks after curative malaria treatment, potentially lead-
ing to over-diagnose of recrudescence and re-infections. 
Based on the observations in this study, it is unclear if 
the DNA origin from residuals of destroyed parasites or 
live gametocytes. Further studies of both P. vivax and P. 
falciparum are needed, since different gametocytaemia 
biology and treatment-regimes have the potential to give 
informative answers.
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